Innate and Adaptive Immune Cell Cross-Talk in Lung Allergy
肺部过敏中的先天性和适应性免疫细胞交叉对话
基本信息
- 批准号:7476187
- 负责人:
- 金额:$ 33.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-04-01 至 2013-03-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAdjuvantAffectAllergensAllergicAnimal ModelAntibodiesAntigensAspergillusAsthmaAttenuatedB-LymphocytesBacterial InfectionsBasophilsBiological MarkersCD4 Positive T LymphocytesCell WallCellsCharacteristicsChitinChitinaseClinicalComplexCrustaceaDendritic CellsDendritic cell activationDeveloped CountriesDeveloping CountriesDiseaseElementsElevationFeedbackFibrosisGene-ModifiedHelminthsHelper-Inducer T-LymphocyteHumanHyperplasiaHypersensitivityIgEImmuneImmune responseImmunityIncidenceInfiltrationInflammationInflammatoryInsectaInterleukin-13Interleukin-4KnowledgeLeadLigandsLungLung diseasesMediatingModelingMucous MembraneMucous body substanceMusNumbersPatientsPhenotypePrevalenceProcessProteinsRegulationReportingRoleSignal TransductionStructure of lymph node of thoraxStructure of parenchyma of lungSystemT-LymphocyteTh1 CellsTh2 CellsThinkingTissuesUnited StatesViralairborne allergenairway hyperresponsivenessantigen challengearginasecell typecytokineenvironmental agenteosinophilfungushuman diseasehuman studyimmunopathologyin vivoinsightlung injurylymph nodesmacrophagemast cellmicrobialmouse modelneutrophilnovelreceptorresearch studyresponse
项目摘要
Asthma is a complex inflammatory disease thought to reflect a dysregulated immune state that is established
by elevated levels of the cytokines IL-4 and IL-13 in lung tissues. Increased numbers of innate and adaptive
IL-4/IL-13-expressing cells, including Th2 cells, eosinophils, basophils and mast cells are found in chronically
affected lung, and elevated levels of IgE are believed to contribute to sensitivity to aeroallergens. Despite
the discovery of microbial ligands for receptors that induce inflammatory T helper cells subsets, including
Th1 cells and Th17 cells, few molecular markers are known which induce immune responses by the
characteristic cell types involved in allergy and asthma. We have recently discovered that a common
constituent associated with many allergens is capable of inducing influx of eosinophils and basophils into the
lungs of mice. Further, instillation induced the accumulation of alternatively activated macrophages, which
are increasingly being recognized as a critical element of allergic immunity. This project will explore the
contributions by this constituent component of helminths, insects and fungal cell walls in provoking changes
in dendritic cells that mediate differentiation of Th2 cells, recruitment of innate IL-4/IL-13-producing cells,
induction of B cell responses leading to IgE and lgG1, and ultimately a mucosal and tissue response. Using
mice with genes modified to report faithful expression of key components of Th2-associated immunity, three
specific aims are proposed:
1. To assess the role of chitin as an adjuvant and as a component of a fungal extract of Aspergillus in
inducing dendritic cell activation in vivo.
2. To assess the role of chitin as an adjuvant and as a component of a fungal extract of Aspergillus in
inducing Th2 cells and IL-4-dependent antibody isotypes.
3. To assess the role of chitin in the induction of feedback mechanisms that limit the inflammatory process in
the lungs.
LAY SUMMARY: The prevalence of asthma remains extensive in the United States and other developed
countries. Knowledge of precise environmental agents that contribute to asthma and that can be studied in
model animal systems is incomplete. This proposal will use mice to study novel and relevant mechanisms.
哮喘是一种复杂的炎症性疾病,被认为反映了一种免疫失调状态,
肺组织中细胞因子IL-4和IL-13水平升高。先天和适应性的数量增加
IL-4/IL-13表达细胞,包括Th 2细胞、嗜酸性粒细胞、嗜碱性粒细胞和肥大细胞,在慢性炎症中发现。
受影响的肺和IgE水平升高被认为有助于对空气过敏原的敏感性。尽管
发现了诱导炎性T辅助细胞亚群的受体的微生物配体,包括
Th 1细胞和Th 17细胞,很少有已知的分子标志物通过免疫球蛋白诱导免疫应答。
与过敏和哮喘有关的典型细胞类型。我们最近发现,
与许多过敏原相关的成分能够诱导嗜酸性粒细胞和嗜碱性粒细胞流入
老鼠的肺此外,滴注诱导了交替激活的巨噬细胞的积累,
越来越多地被认为是过敏性免疫的关键因素。本项目将探讨
蠕虫、昆虫和真菌细胞壁的这种组成成分在引起变化方面的贡献
在介导Th 2细胞分化的树突细胞中,募集先天性IL-4/IL-13产生细胞,
诱导B细胞应答,导致IgE和IgG 1,并最终导致粘膜和组织应答。使用
基因修饰的小鼠报告了Th 2相关免疫的关键成分的忠实表达,
提出了具体目标:
1.为了评估几丁质作为佐剂和作为曲霉菌提取物的组分的作用,
在体内诱导树突细胞活化。
2.为了评估几丁质作为佐剂和作为曲霉菌提取物的组分的作用,
诱导Th 2细胞和IL-4依赖性抗体同种型。
3.为了评估几丁质在诱导限制炎症过程的反馈机制中的作用,
肺
摘要:哮喘的患病率在美国和其他发达国家仍然很高。
国家了解导致哮喘的确切环境因素,并可在
动物模型是不完整的。该提案将使用小鼠研究新的相关机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Richard M Locksley其他文献
Richard M Locksley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Richard M Locksley', 18)}}的其他基金
ILC2 and epithelial cell heterogeneity and self-sustaining type 2 airway niches in asthma
ILC2 和上皮细胞异质性以及哮喘中自我维持的 2 型气道生态位
- 批准号:
10472534 - 财政年份:2012
- 资助金额:
$ 33.06万 - 项目类别:
ILC2 and epithelial cell heterogeneity and self-sustaining type 2 airway niches in asthma
ILC2 和上皮细胞异质性以及哮喘中自我维持的 2 型气道生态位
- 批准号:
10681273 - 财政年份:2012
- 资助金额:
$ 33.06万 - 项目类别:
ILC2 and epithelial cell heterogeneity and self-sustaining type 2 airway niches in asthma
ILC2 和上皮细胞异质性以及哮喘中自我维持的 2 型气道生态位
- 批准号:
10226876 - 财政年份:2012
- 资助金额:
$ 33.06万 - 项目类别:
ILC2 and epithelial cell heterogeneity and self-sustaining type 2 airway niches in asthma
ILC2 和上皮细胞异质性以及哮喘中自我维持的 2 型气道生态位
- 批准号:
10006351 - 财政年份:2012
- 资助金额:
$ 33.06万 - 项目类别:
相似海外基金
Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
- 批准号:
23K08213 - 财政年份:2023
- 资助金额:
$ 33.06万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
- 批准号:
2881726 - 财政年份:2023
- 资助金额:
$ 33.06万 - 项目类别:
Studentship
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
- 批准号:
10735090 - 财政年份:2023
- 资助金额:
$ 33.06万 - 项目类别:
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
- 批准号:
10722146 - 财政年份:2023
- 资助金额:
$ 33.06万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 33.06万 - 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
- 批准号:
10935776 - 财政年份:2023
- 资助金额:
$ 33.06万 - 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
- 批准号:
10935796 - 财政年份:2023
- 资助金额:
$ 33.06万 - 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
- 批准号:
10935775 - 财政年份:2023
- 资助金额:
$ 33.06万 - 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
- 批准号:
10735964 - 财政年份:2023
- 资助金额:
$ 33.06万 - 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
- 批准号:
10649041 - 财政年份:2023
- 资助金额:
$ 33.06万 - 项目类别:














{{item.name}}会员




